Showing results (161-170 of 239) with videos related to
Sort By:
Pageof 24
Plos One|September 21, 2017
Challenges and advances for transcriptome assembly in non-model speciesArnaud Ungaro, Nicolas Pech, Jean-François Martin, et al.Environmental Toxicology and Chemistry|January 20, 2023
Variation of Tolerance to Isothiazolinones Among Daphnia pulex ClonesMargot Wagner-Deyriès, Léa Varignier, Marion Revel, et al.Familial Cancer|October 24, 2003
Profuse familial adenomatous polyposis with an adenomatous polyposis coli exon 3 mutationS Nasioulas, I T Jones, D J St John, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Mutational analysis of the first 14 exons of the adenomatous polyposis coli (APC) geneZ Dobbie, M Spycher, R Hürliman, et al.Virchows Archiv : an International Journal of Pathology|February 9, 2000
Blomstrand osteochondrodysplasia: three novel cases and histological evidence for heterogeneityR J Oostra, J J van der Harten, W P Rijnders, et al.Gut|November 21, 1998
Phenotypic differences in familial adenomatous polyposis based on APC gene mutation statusK Heinimann, B Müllhaupt, W Weber, et al.Oncogene|August 18, 1997
New deletion in low-grade oligodendroglioma at the glioblastoma suppressor locus on chromosome 10q25-26D Maier, D Comparone, E Taylor, et al.Molecular Psychiatry|July 6, 2011
Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cellsE Gardiner, N J Beveridge, J Q Wu, et al.Journal of Medical Genetics|September 1, 1996
BRCA1 mutations in a selected series of breast/ovarian cancer patientsA M Garvin, M Spycher, M Häner, et al.Alimentary Pharmacology & Therapeutics|July 6, 2004
Alosetron repeat dose pharmacokinetics, effects on enzyme activities, and influence of demographic factorsK M Koch, B W Corrigan, J Manzo, et al.Pageof 24